No survival benefit for patients with melanoma undergoing sentinel lymph node biopsy: critical appraisal of the Multicenter Selective Lymphadenectomy Trial-I final report.
Identifieur interne : 001A55 ( Main/Merge ); précédent : 001A54; suivant : 001A56No survival benefit for patients with melanoma undergoing sentinel lymph node biopsy: critical appraisal of the Multicenter Selective Lymphadenectomy Trial-I final report.
Auteurs : M. Sladden [Australie] ; S. Zagarella ; C. Popescu ; M. BigbySource :
- The British journal of dermatology [ 1365-2133 ] ; 2015.
Descripteurs français
- KwdFr :
- MESH :
- anatomopathologie : Mélanome, Tumeurs cutanées.
- Biopsie de noeud lymphatique sentinelle, Femelle, Humains, Lymphadénectomie, Mâle.
English descriptors
- KwdEn :
- MESH :
- pathology : Melanoma, Skin Neoplasms.
- Female, Humans, Lymph Node Excision, Male, Sentinel Lymph Node Biopsy.
Abstract
Sentinel lymph node biopsy (SLNB) was developed in the hope that it would improve outcomes for patients with melanoma. SLNB is an area of discussion and controversy in melanoma medicine. The final trial results of the Multicenter Selective Lymphadenectomy Trial (MSLT-I) have now been published and the authors suggest their long-term results 'clearly validate the use of sentinel-node biopsy in patients with intermediate-thickness or thick primary melanomas'. An accompanying editorial states that MSLT-I is a practice-changing trial.
DOI: 10.1111/bjd.13675
PubMed: 25776246
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 000F84
- to stream PubMed, to step Curation: 000F84
- to stream PubMed, to step Checkpoint: 000F84
- to stream Ncbi, to step Merge: 007144
- to stream Ncbi, to step Curation: 007144
- to stream Ncbi, to step Checkpoint: 007144
Links to Exploration step
pubmed:25776246Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">No survival benefit for patients with melanoma undergoing sentinel lymph node biopsy: critical appraisal of the Multicenter Selective Lymphadenectomy Trial-I final report.</title>
<author><name sortKey="Sladden, M" sort="Sladden, M" uniqKey="Sladden M" first="M" last="Sladden">M. Sladden</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Medicine, University of Tasmania, 36 Thistle St West, South Launceston, Tasmania, 7249, Australia. m.sladden@doctors.org.uk.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Department of Medicine, University of Tasmania, 36 Thistle St West, South Launceston, Tasmania, 7249</wicri:regionArea>
<wicri:noRegion>7249</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Zagarella, S" sort="Zagarella, S" uniqKey="Zagarella S" first="S" last="Zagarella">S. Zagarella</name>
</author>
<author><name sortKey="Popescu, C" sort="Popescu, C" uniqKey="Popescu C" first="C" last="Popescu">C. Popescu</name>
</author>
<author><name sortKey="Bigby, M" sort="Bigby, M" uniqKey="Bigby M" first="M" last="Bigby">M. Bigby</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2015">2015</date>
<idno type="RBID">pubmed:25776246</idno>
<idno type="pmid">25776246</idno>
<idno type="doi">10.1111/bjd.13675</idno>
<idno type="wicri:Area/PubMed/Corpus">000F84</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000F84</idno>
<idno type="wicri:Area/PubMed/Curation">000F84</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000F84</idno>
<idno type="wicri:Area/PubMed/Checkpoint">000F84</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000F84</idno>
<idno type="wicri:Area/Ncbi/Merge">007144</idno>
<idno type="wicri:Area/Ncbi/Curation">007144</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">007144</idno>
<idno type="wicri:Area/Main/Merge">001A55</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">No survival benefit for patients with melanoma undergoing sentinel lymph node biopsy: critical appraisal of the Multicenter Selective Lymphadenectomy Trial-I final report.</title>
<author><name sortKey="Sladden, M" sort="Sladden, M" uniqKey="Sladden M" first="M" last="Sladden">M. Sladden</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Medicine, University of Tasmania, 36 Thistle St West, South Launceston, Tasmania, 7249, Australia. m.sladden@doctors.org.uk.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Department of Medicine, University of Tasmania, 36 Thistle St West, South Launceston, Tasmania, 7249</wicri:regionArea>
<wicri:noRegion>7249</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Zagarella, S" sort="Zagarella, S" uniqKey="Zagarella S" first="S" last="Zagarella">S. Zagarella</name>
</author>
<author><name sortKey="Popescu, C" sort="Popescu, C" uniqKey="Popescu C" first="C" last="Popescu">C. Popescu</name>
</author>
<author><name sortKey="Bigby, M" sort="Bigby, M" uniqKey="Bigby M" first="M" last="Bigby">M. Bigby</name>
</author>
</analytic>
<series><title level="j">The British journal of dermatology</title>
<idno type="eISSN">1365-2133</idno>
<imprint><date when="2015" type="published">2015</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Female</term>
<term>Humans</term>
<term>Lymph Node Excision</term>
<term>Male</term>
<term>Melanoma (pathology)</term>
<term>Sentinel Lymph Node Biopsy</term>
<term>Skin Neoplasms (pathology)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Biopsie de noeud lymphatique sentinelle</term>
<term>Femelle</term>
<term>Humains</term>
<term>Lymphadénectomie</term>
<term>Mâle</term>
<term>Mélanome (anatomopathologie)</term>
<term>Tumeurs cutanées (anatomopathologie)</term>
</keywords>
<keywords scheme="MESH" qualifier="anatomopathologie" xml:lang="fr"><term>Mélanome</term>
<term>Tumeurs cutanées</term>
</keywords>
<keywords scheme="MESH" qualifier="pathology" xml:lang="en"><term>Melanoma</term>
<term>Skin Neoplasms</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Female</term>
<term>Humans</term>
<term>Lymph Node Excision</term>
<term>Male</term>
<term>Sentinel Lymph Node Biopsy</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Biopsie de noeud lymphatique sentinelle</term>
<term>Femelle</term>
<term>Humains</term>
<term>Lymphadénectomie</term>
<term>Mâle</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Sentinel lymph node biopsy (SLNB) was developed in the hope that it would improve outcomes for patients with melanoma. SLNB is an area of discussion and controversy in melanoma medicine. The final trial results of the Multicenter Selective Lymphadenectomy Trial (MSLT-I) have now been published and the authors suggest their long-term results 'clearly validate the use of sentinel-node biopsy in patients with intermediate-thickness or thick primary melanomas'. An accompanying editorial states that MSLT-I is a practice-changing trial.</div>
</front>
</TEI>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Main/Merge
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001A55 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Merge/biblio.hfd -nk 001A55 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Sante |area= LymphedemaV1 |flux= Main |étape= Merge |type= RBID |clé= pubmed:25776246 |texte= No survival benefit for patients with melanoma undergoing sentinel lymph node biopsy: critical appraisal of the Multicenter Selective Lymphadenectomy Trial-I final report. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Merge/RBID.i -Sk "pubmed:25776246" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Merge/biblio.hfd \ | NlmPubMed2Wicri -a LymphedemaV1
![]() | This area was generated with Dilib version V0.6.31. | ![]() |